Novo Nordisk (NYSE:NVO)
Novo Nordisk, world leader in diabetes treatment, offers a complete range of innovative solutions, from modern insulins to customized injection systems. Despite a high valuation and high volatility, the company has posted impressive earnings and dividend growth, driven by the steady increase in diabetes cases worldwide.
Novo Nordisk (NYSE:NVO) Read More »